WuXi Biologics (Cayman) Inc (WXXWY)
3.36
+0.13
(+4.02%)
USD |
OTCM |
Apr 26, 15:59
WuXi Biologics Revenue (TTM): 2.398B for Dec. 31, 2023
Revenue (TTM) Chart
Historical Revenue (TTM) Data
| Date | Value |
|---|---|
| December 31, 2023 | 2.398B |
| June 30, 2023 | 2.345B |
| December 31, 2022 | 2.224B |
| June 30, 2022 | 2.010B |
| December 31, 2021 | 1.601B |
| June 30, 2021 | 1.235B |
| December 31, 2020 | 827.41M |
| June 30, 2020 | 611.55M |
| Date | Value |
|---|---|
| December 31, 2019 | 572.96M |
| June 30, 2019 | 449.61M |
| December 31, 2018 | 379.57M |
| June 30, 2018 | 311.41M |
| December 31, 2017 | 241.22M |
| June 30, 2017 | 179.31M |
| December 31, 2016 | 146.74M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (TTM) Range, Past 5 Years
449.61M
Minimum
Jun 2019
2.398B
Maximum
Dec 2023
1.427B
Average
1.418B
Median
Revenue (TTM) Benchmarks
| Wuxi AppTec Co Ltd | 5.698B |
| Zai Lab Ltd | 266.72M |
| I-MAB | -35.63M |
| Gracell Biotechnologies Inc (DELISTED) | -- |
| Sinovac Biotech Ltd | 420.88M |